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The formation of the skeleton
requires the carefully coordinated
interplay of many cell types and a
myriad structural, metabolic and
regulatory factors. During human
embryogenesis, the skeleton arises
from three separate lineages: the
neural crest generates most of the
bones of the face and skull; the lateral
plate mesoderm, the pelvic and
shoulder girdles and the long bones of
the limbs; and the sclerotome, most of
the axial skeleton. The first signs of
skeletal development are apparent
toward the end of the fourth week of
embryogenesis when the sclerotome
cells form a loosely woven tissue
termed the mesenchyme. This
process is then mirrored by cells from
the other skeletal lineages. The
mesenchymal cells migrate and
condense to form individual skeletal
elements under the control of many
autocrine and paracrine factors such as
the bone morphogenetic proteins,
fibroblast growth factors (FGFs) and
Sonic hedgehog.
Mesenchymal cells within
developing skeletal elements can
differentiate into many cell types
such as fibroblasts, chondrocytes or
osteoblasts. In the formation of the
flat, plate-like bone structures, such
as of the skull and mandibles, the
cells differentiate directly into bone-
depositing osteoblasts under the
direction of the transcription factor
Cbfa-1. This process is termed
intramembranous ossification. Where
controlled longitudinal growth is
essential, such as in the phalanges,
the limbs, ribs and vertebrae, the
mesenchymal cells differentiate into
chondrocytes that deposit a
cartilaginous model of the individual
skeletal elements in response to the
transcription factor Sox-9. The
conversion of this cartilaginous model
to bone with accompanying
longitudinal growth is called
endochondral ossification. This
process requires a temporal and
spatial balance between extracellular
matrix deposition and degradation,
chondrocyte proliferation and
apoptosis plus vascularisation and
mineralisation. Disruption of any
aspect of this process can lead to a
spectrum of skeletal defects that
ranges from mild to lethal and from
rare to common. This primer
introduces the process of
endochondral ossification, its key
regulatory factors and associated
disorders.
Endochondral ossification
Once the cartilaginous model of the
bone has been formed, chondrocytes
within the centre of the shaft, the
diaphysis, begin to increase in
number and size. Hypertrophy of
these chondrocytes is associated with
apoptosis, matrix calcification and
vascular invasion. The blood vessels
bring with them stem cells of
different lineages that give rise to the
bone depositing osteoblasts and the
bone resorbing osteoclasts. The
invading cells stimulate the removal
of the calcified cartilage and its
replacement by trabecular bone and
bone marrow. As the bone marrow
cavity expands toward the epiphyses
— the ends of the bone — the
chondrocytes at the epiphyseal
margin proliferate rapidly forming
longitudinal columns of flattened
chondrocytes. Thus, between the
cartilaginous epiphysis and the newly
generated bone, the primary growth
plate forms with the characteristic
zones of resting, proliferative,
maturing and hypertrophic
chondrocytes (Figure 1). Within the
growth plate, chondrocyte
proliferation is balanced by
chondrocyte apoptosis and the
replacement of the calcified cartilage
with bone thereby maintaining the
width of the growth plate during
development. Later in development,
roughly spherical secondary centres
of ossification form within the
Figure 1
Histological section of a mouse growth plate showing distinct zones of chondrocyte
differentiation. Courtesy of Dr Ray Boot-Handford.
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cartilaginous epiphyses. Longitudinal
bone growth continues until puberty
when chondrocyte proliferation
ceases and the primary and secondary
centres of ossification fuse. A thin
layer of cartilage covering the joint
surface remains, however, throughout
adulthood, protecting the underlying
bone and providing a smooth surface
for articulation.
Role of the extracellular matrix
Chondrocytes secrete an extracellular
matrix that is composed mainly of
collagen types II, IX and XI, with
type X collagen in the hypertrophic
zone, proteoglycans such as aggrecan
and perlecan, and non-collagenous
proteins such as cartilage oligomeric
matrix protein and matrilins-1 and 3.
Mutations in most of the encoding
genes have been shown to cause
heritable disorders of skeletal
morphology and growth, termed the
chondrodysplasias. The classic view of
cartilage has been that the highly
negatively charged proteoglycans hold
water allowing deformation and
subsequent recovery of the matrix
whilst the collagen meshwork
restrains swelling of the tissue
preventing excessive distortion. In
addition to this structural role,
however, the extracellular matrix also
has a significant impact on
chondrocyte differentiation within the
growth plate. For example,
proteoglycans play an essential role in
the binding and presentation of
important signalling molecules such as
FGFs and Indian hedgehog (Ihh) to
their receptors. A range of
chondrodysplasias, including the
lethal condition achondrogenesis
type 1B, is caused by defective
sulphate transport, leading to under-
sulphation of proteoglycans and
consequently aberrant FGF
signalling. Defective polymerisation
of proteoglycan glycosaminoglycan
chains restricts the range of Ihh
signalling and leads to the formation
of protruding cartilaginous nodules
from the growth plate in the condition
hereditary multiple exostoses.
Extra-structural roles for the collagens
have also been implicated in
chondrocyte differentiation. For
example, mice lacking type II
collagen show increased chondrocyte
apoptosis, suggesting that this
collagen provides an attachment
substrate and essential survival signals.
Chondrocyte differentiation
The rapid proliferation of
chondrocytes within the constraints of
the cartilaginous matrix leads to
formation of the characteristic orderly
columns of chondrocytes seen in the
growth plate. It is this stage of
chondrocyte differentiation which
facilitates longitudinal bone growth.
Both autocrine and paracrine factors
play roles in controlling the rate of
chondrocyte proliferation. Growth
hormone, produced in the pituitary,
induces the local production of
insulin-like growth factors which
promote proliferation. Chondrocyte
proliferation is balanced by negative
regulation, the best characterised
pathway being via FGF receptor 3
(FGFR3). Mutations in FGFR3,
which is expressed in the resting
zone, cause the most common form of
dwarfism, achondroplasia, the milder
hypochondroplasia and the lethal
thanatophoric dysplasia. These
mutations lead to constitutive
activation of the receptor resulting in
reduced chondrocyte proliferation
while knocking out the receptor in
mice leads to skeletal overgrowth.
Thus activation of FGFR3 appears to
stop cells entering the proliferative
phase, most likely via the up
regulation of cell cycle inhibitors.
The maturation zone between
proliferation and hypertrophy
represents the site of active control
over chondrocyte exit from the cell
cycle and entry into hypertrophy
which sets the pace of differentiation.
Regulation of chondrocyte exit from
the cell cycle is poorly understood
whereas the regulation of entry into
hypertophy is one of the better
understood areas of chondrocyte
biology. In this latter process,
parathyroid hormone related peptide,
PTHrP, and the secreted factor Ihh
play crucial roles. Ihh is expressed by
chondrocytes in the lower part of the
maturation zone, which are already
committed to hypertrophy. Ihh
induces PTHrP expression in the
perichondrium. PTHrP diffuses into
the maturation zone where its
receptor is expressed, and prevents
further chondrocyte differentiation.
Once Ihh expressing cells have
undergone hypertrophy they stop
producing Ihh. Thus PTHrP and Ihh
form a negative feedback loop to
regulate entry into hypertrophy
(Figure 2). Ihh is also a positive
regulator of chondrocyte proliferation
and osteoblast differentiation and is
thus critical for many aspects of
endochondrial ossification.
During hypertrophy, the
chondrocytes increase in size by five
to ten-fold and thereby contribute to
long bone growth. They also prepare
the cartilage matrix for vascular
invasion and bone deposition.
Intrinsic to both of these functions is
the need for matrix remodelling,
which consists both of matrix
degradation and deposition of new
matrix components. Degradation of
the cartilage matrix involves cleavage
of collagen by matrix
metalloproteinases (MMPs) such as
MMP-13 and MMP-2 from the
collagenase and gelatinase subgroups
respectively; proteoglycans are
largely degraded by stromelysins,
such as MMP-10, and the
aggrecanases. MMPs can also remove
anti-angiogenic molecules and
generate angiogenic molecules either
by releasing them from a matrix
bound state or by forming angiogenic
fragments from larger molecules.
Hypertrophic cells secrete a
unique matrix component, the short
chain type X collagen. This collagen
is thought to form a hexagonal lattice
‘basket’ around the expanding
chondrocytes, which may provide
structural support as they expand and
degrade other matrix molecules.
Recent studies of a strain of mice
lacking type X collagen show that
they have defective haematopoiesis,
suggesting that the remaining
spicules of hypertrophic chondrocyte
matrix may have an essential role in
directing the development of the
haematopoietic cells of the bone
marrow.
In addition to type X collagen,
hypertrophic chondrocytes also
secrete matrix molecules such as
osteopontin, osteonectin and bone
sialoprotein which were once thought
to be uniquely produced by
osteoblasts. These molecules create a
scaffold for the attachment and
differentiation of the osteoblast and
osteoclast precursor cells. The
production of these proteins is under
the control of the master regulator of
the osteoblast phenotype, the
transcription factor Cbfa-1, which is
also required for the terminal
differentiation of hypertrophic
chondrocytes. Expression of bone
markers by chondrocytes has led to
the controversial opinion that they
are transdifferentiating. However
there is now overwhelming evidence
that the fate of hypertrophic
chondrocyte is apoptosis, mediated
by the downregulation of the anti-
apoptotic Bcl-2, leading to an
imbalance with the levels of its pro-
apoptotic partner Bax. The final
trigger for apoptosis appears to
depend on signals from the invading
vasculature. This has been
highlighted by analysis of the MMP-9
knockout mouse. MMP-9 is
produced by osteoclasts at the
chondro–osseous junction, and its
absence delays vascular invasion,
probably through decreased
production of an angiogenic factor,
and also delays hypertrophic
chondrocyte apoptosis. This
signalling interplay highlights the
complex reciprocal regulation that
exists between the chondrocytes and
the invading vasculature.
Endochondral ossification
represents a fascinating combination
of virtually every known biological
pathway. Precisely how these
pathways are integrated in the
formation of a skeleton with
elements of the appropriate size,
shape and structure remains however
a major challenge.
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Figure 2
Key regulators of chondrocyte differentiation within the growth plate.
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